13D/13G Filings - Invus Public Equities, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-08-02
6:38 pm
Purchase
2024-07-25 13G HOOKIPA Pharma Inc.
HOOK
Invus Public Equities, L.P. 566,640
5.900%
566,640increase
(New Position)
Filing
History
2024-08-02
6:37 pm
Purchase
2024-07-25 13G Solid Biosciences Inc.
SLDB
Invus Public Equities, L.P. 2,508,143
6.500%
2,508,143increase
(New Position)
Filing
History
2024-08-02
6:33 pm
Purchase
2024-07-25 13G Seer, Inc.
SEER
Invus Public Equities, L.P. 4,195,185
6.900%
4,195,185increase
(New Position)
Filing
History
2024-08-02
6:30 pm
Purchase
2024-07-25 13G Gossamer Bio, Inc.
GOSS
Invus Public Equities, L.P. 14,358,880
6.300%
14,358,880increase
(New Position)
Filing
History
2024-08-02
6:25 pm
Purchase
2024-07-25 13G AlloVir, Inc.
ALVR
Invus Public Equities, L.P. 286,833
5.700%
286,833increase
(New Position)
Filing
History
2024-07-29
7:27 pm
Purchase
2024-07-25 13G Scholar Rock Holding Corporation
SRRK
Invus Public Equities, L.P. 12,834,446
15.800%
12,834,446increase
(New Position)
Filing
History
2024-07-29
7:24 pm
Purchase
2024-07-25 13G GlycoMimetics, Inc.
GLYC
Invus Public Equities, L.P. 8,589,064
13.300%
8,589,064increase
(New Position)
Filing
History
Goto Prev, 0, 1